What’s new

img
These steelworkers want a U.S. Steel sale. Biden and Trump don’t. - The Washington Post

Many Pennsylvania steelworkers welcome Nippon buying U.S. Steel. But both political and union leaders oppose the takeover these steelworkers say is the last, best chance.

Todays Pick

Big Lots store closings 2025: Retailer plans to close all stores - Axios

Discount retailer Big Lots plans to liquidate its remaining stores after restructuring plans collapsed.

Trending News
Newsletter

Stay Updated on all News and articles

Subscribe Now

Trending News

Two Oregon Party City locations to close as company ceases operations - KATU

Party City, the long-standing party supply chain, will be closing all its stores after 40 years.

JPMorgan, Wells Fargo, BofA facing federal lawsuit over Zelle payment network fraud - New York Post

A federal regulator sued JPMorgan Chase, Wells Fargo and Bank of America on Friday, claiming the banks failed to protect hundreds of thousands of consumers from rampant fraud on the popular payment…

Big Lots store closings 2025: Retailer plans to close all stores - Axios

Discount retailer Big Lots plans to liquidate its remaining stores after restructuring plans collapsed.

The Fed cut interest rates but mortgage costs jumped. Here's why - CNBC

The average 30-year fixed mortgage rate spiked after the Federal Reserve cut rates. Experts say expectations for rate cuts in 2025 fueled the jump.

Volkswagen agrees deal to avoid Germany plant closures - BBC.com

VW and a union have, however, agreed to cut more than 35,000 jobs across the country by 2030.

Stock Market Today: Dow Jones Soars As Nvidia Bounces; Speaker Johnson Promises This (Live Coverage) - Investor's Business Daily

The Dow Jones rose on the stock market today as a government shutdown looms. Nvidia rose while Tesla fell along with a Trump stock.

What Novo Nordisk’s disappointing trial results mean for the obesity drug market - STAT

New clinical trial data from Novo Nordisk raise questions for the broad landscape of obesity drug development and the way investors view emerging candidates.